Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Font

Showing results (411-420 of 423) with videos related to

Pageof 43
Sort By:
Annals of the Rheumatic Diseases|April 25, 2008
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpointsG K Bertsias, J P A Ioannidis, J Boletis, et al.
Annals of the Rheumatic Diseases|May 17, 2007
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including TherapeuticsG Bertsias, J P A Ioannidis, J Boletis, et al.
Annals of the Rheumatic Diseases|January 22, 2009
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamideF A Houssiau, C Vasconcelos, D D'Cruz, et al.
Medicine|November 13, 2001
Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patientsR A Asherson, R Cervera, J C Piette, et al.
Annals of the Rheumatic Diseases|April 5, 2008
EULAR points to consider for conducting clinical trials in systemic lupus erythematosusC Gordon, G Bertsias, J P A Ioannidis, et al.
Lupus|August 31, 2007
Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohortM B Urowitz, D Gladman, D Ibañez, et al.
Arthritis and Rheumatism|February 2, 2008
Accumulation of coronary artery disease risk factors over three years: data from an international inception cohortM B Urowitz, D Gladman, D Ibañez, et al.
Arthritis and Rheumatism|December 30, 2006
Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort studyJ G Hanly, M B Urowitz, J Sanchez-Guerrero, et al.
Journal of Clinical Immunology|November 7, 2003
Prevalence and clinical correlations of antibodies against six beta2-glycoprotein-I-related peptides in the antiphospholipid syndromeY Shoenfeld, I Krause, F Kvapil, et al.
Arthritis and Rheumatism|April 29, 2008
Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort studyJ G Hanly, M B Urowitz, L Su, et al.
Pageof 43

Showing results (411-420 of 423) with videos related to

Sort By:
Pageof 43
Annals of the Rheumatic Diseases|April 25, 2008
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpointsG K Bertsias, J P A Ioannidis, J Boletis, et al.
Annals of the Rheumatic Diseases|May 17, 2007
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including TherapeuticsG Bertsias, J P A Ioannidis, J Boletis, et al.
Annals of the Rheumatic Diseases|January 22, 2009
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamideF A Houssiau, C Vasconcelos, D D'Cruz, et al.
Medicine|November 13, 2001
Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patientsR A Asherson, R Cervera, J C Piette, et al.
Annals of the Rheumatic Diseases|April 5, 2008
EULAR points to consider for conducting clinical trials in systemic lupus erythematosusC Gordon, G Bertsias, J P A Ioannidis, et al.
Lupus|August 31, 2007
Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohortM B Urowitz, D Gladman, D Ibañez, et al.
Arthritis and Rheumatism|February 2, 2008
Accumulation of coronary artery disease risk factors over three years: data from an international inception cohortM B Urowitz, D Gladman, D Ibañez, et al.
Arthritis and Rheumatism|December 30, 2006
Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort studyJ G Hanly, M B Urowitz, J Sanchez-Guerrero, et al.
Journal of Clinical Immunology|November 7, 2003
Prevalence and clinical correlations of antibodies against six beta2-glycoprotein-I-related peptides in the antiphospholipid syndromeY Shoenfeld, I Krause, F Kvapil, et al.
Arthritis and Rheumatism|April 29, 2008
Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort studyJ G Hanly, M B Urowitz, L Su, et al.
Pageof 43